{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:02:10Z","timestamp":1790625730489,"version":"4.1.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Interferon (IFN) is a key component of the innate immune response. For reasons that remain incompletely understood, the IFN system is upregulated in several rheumatic diseases, particularly those that feature autoantibody production, such as SLE, Sj\u00f6gren\u2019s syndrome, myositis and systemic sclerosis. Interestingly, many of the autoantigens targeted in these diseases are components of the IFN system, representing IFN-stimulated genes (ISGs), pattern recognition receptors (PRRs), and modulators of the IFN response. In this review, we describe features of these IFN-linked proteins that may underlie their status as autoantigens. Note is also made of anti-IFN autoantibodies that have been described in immunodeficiency states.<\/jats:p>","DOI":"10.3389\/fmed.2023.1165225","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:03:40Z","timestamp":1683608620000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Interferon and autoantigens: intersection in autoimmunity"],"prefix":"10.3389","volume":"10","author":[{"given":"Brendan","family":"Antiochos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Casciola-Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/08820139.2015.1099409","article-title":"An overview of organ-specific autoimmune diseases including immunotherapy","volume":"44","author":"Mastrandrea","year":"2015","journal-title":"Immunol Investig"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1172\/JCI78084","article-title":"Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity","volume":"125","author":"Suurmond","year":"2015","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"102649","DOI":"10.1016\/j.autrev.2020.102649","article-title":"Hashimoto\u2019s thyroiditis: an update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation","volume":"19","author":"Ralli","year":"2020","journal-title":"Autoimmun Rev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"764062","DOI":"10.3389\/fimmu.2021.764062","article-title":"Type III interferons: emerging roles in autoimmunity","volume":"12","author":"Manivasagam","year":"2021","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/ni.3212","article-title":"Guarding the frontiers: the biology of type III interferons","volume":"16","author":"Wack","year":"2015","journal-title":"Nat Immunol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41577-019-0215-7","article-title":"DAMP-sensing receptors in sterile inflammation and inflammatory diseases","volume":"20","author":"Gong","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nri.2015.8","article-title":"Self-regulation and cross-regulation of pattern-recognition receptor signalling in health and disease","volume":"16","author":"Cao","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1146\/annurev-pathol-020117-043952","article-title":"Type I interferons in autoimmune disease","volume":"14","author":"Crow","year":"2019","journal-title":"Annu Rev Pathol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41584-021-00606-1","article-title":"Interferon lambda in inflammation and autoimmune rheumatic diseases","volume":"17","author":"Goel","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1056\/NEJM197907053010102","article-title":"Immune interferon in the circulation of patients with autoimmune disease","volume":"301","author":"Hooks","year":"1979","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1136\/ard.2008.093146","article-title":"Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus","volume":"68","author":"Landolt-Marticorena","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1177\/0961203309105529","article-title":"Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus","volume":"18","author":"Petri","year":"2009","journal-title":"Lupus"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13075-021-02414-0","article-title":"The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus","volume":"23","author":"Mai","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1002\/art.39204","article-title":"Molecular subsetting of interferon pathways in Sjogren\u2019s syndrome","volume":"67","author":"Hall","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e1193","DOI":"10.1212\/WNL.0000000000008128","article-title":"Identification of distinctive interferon gene signatures in different types of myositis","volume":"93","author":"Pinal-Fernandez","year":"2019","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"17609","DOI":"10.1073\/pnas.1209724109","article-title":"Precise probes of type II interferon activity define the origin of interferon signatures in target tissues in rheumatic diseases","volume":"109","author":"Hall","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/cei.12865","article-title":"Expression of type III interferons (IFN\u03bbs) and their receptor in Sj\u00f6gren\u2019s syndrome","volume":"186","author":"Apostolou","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13075-019-1878-y","article-title":"High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus","volume":"21","author":"Oke","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/art.38628","article-title":"Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures","volume":"66","author":"Chiche","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","article-title":"The type I interferonopathies: 10 years on","volume":"22","author":"Crow","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/j.drudis.2021.06.010","article-title":"IFN-\u03b1: a key therapeutic target for multiple autoimmune rheumatic diseases","volume":"26","author":"De Ceuninck","year":"2021","journal-title":"Drug Discov Today"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-virology-092818-015756","article-title":"Interferon-stimulated genes: what do they all do?","volume":"6","author":"Schoggins","year":"2019","journal-title":"Ann Rev Virol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"738473","DOI":"10.3389\/fimmu.2021.738473","article-title":"TRIM21\/Ro52 - roles in innate immunity and autoimmune disease","volume":"12","author":"Jones","year":"2021","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1084\/jem.20041859","article-title":"Ro\/SSA autoantibodies directly bind cardiomyocytes, disturb calcium homeostasis, and mediate congenital heart block","volume":"201","author":"Salomonsson","year":"2005","journal-title":"J Exp Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e000732","DOI":"10.1136\/lupus-2022-000732","article-title":"Autoantibodies associated with systemic sclerosis in three autoimmune diseases imprinted by type I interferon gene dysregulation: a comparison across SLE, primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"9","author":"Andraos","year":"2022","journal-title":"Lupus Sci Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1002\/art.30187","article-title":"Network analysis of associations between serum interferon-\u03b1 activity, autoantibodies, and clinical features in systemic lupus erythematosus","volume":"63","author":"Weckerle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.4049\/jimmunol.181.3.1780","article-title":"The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3","volume":"181","author":"Higgs","year":"2008","journal-title":"J Immunol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1083\/jcb.201503023","article-title":"TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity","volume":"210","author":"Kimura","year":"2015","journal-title":"J Cell Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"19985","DOI":"10.1073\/pnas.1014074107","article-title":"Antibodies mediate intracellular immunity through tripartite motif-containing 21 (TRIM21)","volume":"107","author":"Mallery","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1073\/pnas.0800159105","article-title":"TRIM21 is an IgG receptor that is structurally, thermodynamically, and kinetically conserved","volume":"105","author":"Keeble","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/rheumatology\/kem338","article-title":"Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases","volume":"47","author":"Schild-Poulter","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"ref36","first-page":"118","article-title":"A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies","volume":"31","author":"Cavazzana","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1177\/0961203316640918","article-title":"Clinical and serological associations of autoantibodies to the Ku70\/Ku80 heterodimer determined by a novel chemiluminescent immunoassay","volume":"25","author":"Mahler","year":"2016","journal-title":"Lupus"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/imm.13318","article-title":"Cytoplasmic-translocated Ku70 senses intracellular DNA and mediates interferon-lambda1 induction","volume":"163","author":"Sui","year":"2021","journal-title":"Immunology"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"aah5054","DOI":"10.1126\/scisignal.aah5054","article-title":"STING is an essential mediator of the Ku70-mediated production of IFN-\u03bb1 in response to exogenous DNA","volume":"10","author":"Sui","year":"2017","journal-title":"Sci Signal"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"111310","DOI":"10.1016\/j.celrep.2022.111310","article-title":"Ku proteins promote DNA binding and condensation of cyclic GMP-AMP synthase","volume":"40","author":"Tao","year":"2022","journal-title":"Cell Rep"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1006\/clin.1994.1187","article-title":"Autoantibodies reacting with poly(ADP-ribose) and with a zinc-finger functional domain of poly(ADP-ribose) polymerase involved in the recognition of damaged DNA","volume":"73","author":"Muller","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1002\/1529-0131(199805)41:5<918::AID-ART20>3.0.CO;2-W","article-title":"Zinc is an essential cofactor for recognition of the DNA binding domain of poly(ADP-ribose) polymerase by antibodies in autoimmune rheumatic and bowel diseases","volume":"41","author":"Decker","year":"1998","journal-title":"Arthritis Rheum"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1016\/j.molcel.2022.03.034","article-title":"Cytoplasmic PARP1 links the genome instability to the inhibition of antiviral immunity through PARylating cGAS","volume":"82","author":"Wang","year":"2022","journal-title":"Mol Cell"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e00047","DOI":"10.7554\/eLife.00047","article-title":"DNA-PK is a DNA sensor for IRF-3-dependent innate immunity","volume":"1","author":"Ferguson","year":"2012","journal-title":"elife"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"6182","DOI":"10.1038\/s41467-020-19941-0","article-title":"DNA-PK deficiency potentiates cGAS-mediated antiviral innate immunity","volume":"11","author":"Sun","year":"2020","journal-title":"Nat Commun"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/ar4486","article-title":"Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma","volume":"16","author":"Moinzadeh","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1101\/gad.333989.119","article-title":"RNA polymerase III transcription as a disease factor","volume":"34","author":"Yeganeh","year":"2020","journal-title":"Genes Dev"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cell.2009.06.015","article-title":"RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway","volume":"138","author":"Chiu","year":"2009","journal-title":"Cells"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","article-title":"Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis","volume":"52","author":"Sato","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/BOR.0000000000000908","article-title":"Anti-MDA5 dermatomyositis: an update from bench to bedside","volume":"34","author":"Fuzzi","year":"2022","journal-title":"Curr Opin Rheumatol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"21010","DOI":"10.1073\/pnas.1113651108","article-title":"Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition","volume":"108","author":"Peisley","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/emboj.2012.19","article-title":"MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA","volume":"31","author":"Berke","year":"2012","journal-title":"EMBO J"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"18437","DOI":"10.1073\/pnas.1212186109","article-title":"MDA5 assembles into a polar helical filament on dsRNA","volume":"109","author":"Berke","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ajhg.2014.12.014","article-title":"A specific IFIH1 gain-of-function mutation causes singleton-Merten syndrome","volume":"96","author":"Rutsch","year":"2015","journal-title":"Am J Hum Genet"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.2933","article-title":"Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling","volume":"46","author":"Rice","year":"2014","journal-title":"Nat Genet"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1002\/art.39110","article-title":"Brief report: IFIH1 mutation causes systemic lupus erythematosus with selective IgA deficiency","volume":"67","author":"van Eyck","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"773352","DOI":"10.3389\/fimmu.2021.773352","article-title":"Dermatomyositis with anti-MDA5 antibodies: bioclinical features, pathogenesis and emerging therapies","volume":"12","author":"Nombel","year":"2021","journal-title":"Front Immunol"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s00296-021-04819-1","article-title":"Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry","volume":"41","author":"Mehta","year":"2021","journal-title":"Rheumatol Int"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/ni.1932","article-title":"IFI16 is an innate immune sensor for intracellular DNA","volume":"11","author":"Unterholzner","year":"2010","journal-title":"Nat Immunol"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"E62","DOI":"10.1073\/pnas.1313577111","article-title":"Cooperative assembly of IFI16 filaments on dsDNA provides insights into host defense strategy","volume":"111","author":"Morrone","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/acr.22632","article-title":"Association of Antibodies to interferon-inducible Protein-16 with markers of more severe disease in primary Sjogren\u2019s syndrome","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/0961203313484978","article-title":"Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus","volume":"22","author":"Caneparo","year":"2013","journal-title":"Lupus"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1002\/art.22266","article-title":"A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16","volume":"54","author":"Mondini","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1365-2567.2005.02197.x","article-title":"Identification of specific autoantigens in Sjogren\u2019s syndrome by SEREX","volume":"116","author":"Uchida","year":"2005","journal-title":"Immunology"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","article-title":"AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC","volume":"458","author":"Hornung","year":"2009","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e72103","DOI":"10.7554\/eLife.72103","article-title":"The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps","volume":"11","author":"Antiochos","year":"2022","journal-title":"elife"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"The adaptor ASC has extracellular and \u2018prionoid\u2019 activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat Immunol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"e120179","DOI":"10.1172\/jci.insight.120179","article-title":"IFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sj\u00f6gren\u2019s syndrome","volume":"3","author":"Antiochos","year":"2018","journal-title":"JCI Insight"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"102381","DOI":"10.1016\/j.jaut.2019.102381","article-title":"Cell-autonomous epithelial activation of AIM2 (absent in melanoma-2) inflammasome by cytoplasmic DNA accumulations in primary Sjogren\u2019s syndrome","volume":"108","author":"Vakrakou","year":"2020","journal-title":"J Autoimmun"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fimmu.2019.01517","article-title":"Functional analysis of anti-cytokine autoantibodies using flow cytometry","volume":"10","author":"Merkel","year":"2019","journal-title":"Front Immunol"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1002\/art.39607","article-title":"Distinct functions of autoantibodies against interferon in systemic lupus erythematosus: a comprehensive analysis of Anticytokine autoantibodies in common rheumatic diseases","volume":"68","author":"Gupta","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1086\/380453","article-title":"Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity","volume":"38","author":"D\u00f6ffinger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","article-title":"Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans","volume":"103","author":"H\u00f6flich","year":"2004","journal-title":"Blood"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"eabp8966","DOI":"10.1126\/sciimmunol.abp8966","article-title":"Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-abs neutralizing type I IFNs","author":"Bastard","year":"2022","journal-title":"Science immunology"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"eabh2624","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1165225\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:03:43Z","timestamp":1683608623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1165225\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":78,"alternative-id":["10.3389\/fmed.2023.1165225"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1165225","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1165225"}}